Gut Microbiota in the Hepato-Cardiorenal Axis: Microbial Metabolites,Inflammation, and Emerging Therapeutic Targets
The gut microbiota significantly influences the hepato-cardiorenal axis through metabolitemediated signalling. While therapeutic modulation shows promise, precision medicine approaches and highquality randomized trials are essential to tackle multi-organ metabolic and inflammatory diseases.
Authors
- Gaurav Doshi (ORCID: https://orcid.org/0000-0002-8490-0705)
- S. K. Tayade and D. A. Patil
Institutions
- Shri Vile Parle Kelavani Mandal (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2026-01-14
- DOI
- https://doi.org/10.2174/0113816128413464251209115653
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00